Search
for
Sort by
Research 541–570 of 1000+
- Dysregulation of Leukaemia Inhibitory Factor (LIF) Signalling Pathway by Supraphysiological Dose of Testosterone in Female Sprague Dawley Rats During Development of Endometrial Receptivity
- Natural phenylethanoid glycoside forsythoside A alleviates androgenetic alopecia by selectively inhibiting TRPV3 channels in mice
- Role of DNA Methylation in the Pathogenesis of Skin Disorders: Mechanisms, Inhibitors of Methylation‐Related Enzyme, and Molecular Docking Studies
- Clinical and Dermoscopic Evaluation of the Safety and Efficacy of Oral baricitinib (JAK Inhibitor) in Treatment of Localized Vitiligo Either Alone or with Topical Tacrolimus
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- Experience in treating multifocal alopecia areata in a child with Jak kinase inhibitors
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- LB1007 Systemic treatment with a KLK5 inhibitor shows efficacy in a murine model of Netherton syndrome
- 267 Single- and multiple-ascending dose studies of DS-2325a, a KLK5 inhibitor for the treatment of Netherton syndrome
- LB1045 Inhibition of pyruvate oxidation activates human hair follicle stem cells ex vivo
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties
- 566 Staphylococcus epidermidis for the topical treatment of epidermal growth factor receptor (EGFR) inhibitor-induced dermal toxicity
- Risk of age-related macular degeneration in men receiving 5α-reductase inhibitors: a population-based cohort study
- A Review of JAK Inhibitors for Treatment of Alopecia Areata in the Military Health Care System
- Letter to the Editor: A Review of JAK Inhibitors for Treatment of Alopecia Areata in the Military Healthcare System
- Alopecia due to chemotherapeutics, hedgehog inhibitors, targeted antibody therapies and immune checkpoint inhibitors
- A Narrowed Look Into Plant-Derived Testosterone 5α-Reductase Inhibitors for Androgenetic Alopecia
- Red pomegranate (Punica granatum L.) peel extract mud mask formulation and tyrosinase-inhibition activity test
- Discovery of a novel and highly selective JAK3 inhibitor as a potent hair growth promoter
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Treatment of lichen planopilaris with Janus kinase inhibitors
- NEONATAL INHIBITION OF ANDROGEN ACTIVITY ALTERS THE PROGRAMMING OF BODY WEIGHT AND OREXINERGIC PEPTIDES DIFFERENTIALLY IN MALE AND FEMALE RATS
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- JAK Inhibitor Baricitinib in the Treatment of Oral Lichen Planus: A Case Report
- Alopecia Areata: JAK Inhibitors—PRP and Exosomes
- P718 Observational real-world evidence on the efficacy and safety of Janus Kinase inhibitors (JAKi) in the treatment of moderate to severe Active Ulcerative Colitis (UC)
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Neonatal inhibition of androgen activity alters the programming of body weight and orexinergic peptides differentially in male and female rats